JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

Summary

Androgenetic alopecia is a common form of progressive hair loss. This prospective single-arm pre-post interventional study aims to assess tissue Janus Kinase 2 (JAK2) expression in patients with androgenetic alopecia by comparing balding and non-balding scalp at baseline, and to evaluate changes in JAK2 expression in balding scalp after 3 months of topical minoxidil 5% therapy. Clinical response will be assessed using standardized trichoscopic parameters.

Timeline

Start

2026-02-01

Primary completion

2026-10-01

Completion

2027-01-01

Drugs

Indications